Cargando…
Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations
Background: A primary goal of asthma management is the reduction of exacerbation risk. We assessed the occurrence of oral corticosteroid-requiring exacerbations (OCS exacerbations) with long-term fluticasone/formoterol therapy, and compared it with the occurrence of similar events reported with othe...
Autores principales: | Papi, Alberto, Mansur, Adel H., Pertseva, Tetyana, Kaiser, Kirsten, McIver, Tammy, Grothe, Birgit, Dissanayake, Sanjeeva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965704/ https://www.ncbi.nlm.nih.gov/pubmed/27104231 http://dx.doi.org/10.1089/jamp.2015.1255 |
Ejemplares similares
-
Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatric asthma patients: a randomized controlled trial
por: Płoszczuk, Anna, et al.
Publicado: (2018) -
The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD
por: Papi, Alberto, et al.
Publicado: (2015) -
Non-interventional study of the safety and effectiveness of
fluticasone propionate/formoterol fumarate in real-world asthma
management
por: Backer, Vibeke, et al.
Publicado: (2018) -
Fluticasone propionate/formoterol for COPD management: a randomized controlled trial
por: Papi, A, et al.
Publicado: (2017) -
The comparison of fluticasone propionate/formoterol with fluticasone propionate/salmeterol for paediatric asthma: a meta-analysis of randomized controlled trials
por: Jin, Xiaofen, et al.
Publicado: (2020)